TECH OFFER

Automated Diagnosis Of The Retinal Image (Normal/Abnormal) Using Deep Neural Network

KEY INFORMATION

TECHNOLOGY CATEGORY:
Healthcare - Telehealth, Medical Software & Imaging
TECHNOLOGY READINESS LEVEL (TRL):
LOCATION:
Singapore
ID NUMBER:
TO174893

TECHNOLOGY OVERVIEW

This technology offers an automated diagnostic solution for retinal health based on fundus image and deep learning technology. The network automatically classifies fundus images of age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma and normal into abnormal and normal classes. The network also can be run on any computing platform, delivering instant results for clinicians and patients.

TECHNOLOGY FEATURES & SPECIFICATIONS

The developed 10-layered neural network can automatically classify images of age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma as abnormal and illustrations of normal subjects as normal. The input image for the system is of size 180 x 270 pixels. The network uses different-sized kernels to interpret the input fundus image, after that, the feature maps are concatenated for analysis.

The system was developed and tested on a total of 2986 images (collected from various sources). 'ADAM' optimizer was used to train the net and achieved an accuracy of 95.24% on a set of 1492 images. A system and method for automated retinal health screening using the deep learning CNN technique is developed. The system automatically classifies images of age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma as an abnormal class and images of normal subjects as a normal class. The CNN entails three main layers, the convolution, pooling, and fully connected layers, with a series of convolution and max pooling steps to provide an accuracy of 96.31%, sensitivity of 97.96%, and specificity of 92.67%. The developed network is commercially ready to deploy to any computing or mobile device.

 

POTENTIAL APPLICATIONS

This automated diagnosis solution can be deployed at any clinical facility for the mass screening and routine screening of the fundus.

Unique Value Proposition

The benefits of the technology include:

  • The diagnosis is fast and reliable.
  • Reduce clinician's workload.
  • Network is compact (small).
  • Readily to be deployed on any computing or mobile device.
RELATED TECH OFFERS
Platform for AI-Assisted Image Labeling, Training, and Deploying AI Models in Healthcare
Unlocking ALS Through Predictive Insights From Deep Learning and Stem Cells
AI Audiologist Device for Hearing Screening
AI-Driven Medical Record Auditing System
Smart Magnetic Sensors for Real-Time Localization of Catheters/Tubes
Cognitive Stimulation Solution to Assist Dementia Patients or Elderly
Smart Sleep Monitoring: Contactless Vital Signs Sensor Based AIoT Solution
Automated Pain Detection using AI
AI-Powered Digital Pathology Solution for Thyroid Cancer Diagnosis
Non-Contact Biosignals Measurement Solution